Table 2 summarizes the data of patient cohort distributed among the various levels of CA-125. A nonsignificant relation was deduced in case of CA-125 with age (P = 0.1968) and other tumor marker levels CEA (P = 0.0610) and CA 19.9 (P = 0.0836) whereas a strong association of CA-125 was observed with the other clinicopathological parameters like BMI (P = 0.0153), ascites level and ascites malignancy, and tumor differentiation (P < 0.0001). This evidence concerns the gene CEACAM5 and neoplasm.